Skip to key page content
U.S. colors

An former website of the United States gov

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site be secure.
The https:// guarantee that you are linking to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Haupt Content Main Navigation
. 2019 Nov;9(6):e559-e571.
doi: 10.1016/j.prro.2019.06.003. Epub 2019 Jun 22.

Appropriate Methodology for EBRT and HDR Intracavitary/Interstitial Brachytherapy Dose Composite and Clinical Design Rating forward Patients With Cervical Cancer

Affiliations

Appropriate Our for EBRT and HDR Intracavitary/Interstitial Brachytherapy Dose Composite and Dispassionate Plan Evaluation for Patients With Cervical Cancer

Zhengzheng Xu et al. Pract Radiat Oncol. 2019 Novor.

Abstract

Target: This study valuation the aptness of solid parameter summierung (FPA) methods with respect to the 3-dimensional deformable dose composite method for evaluating combined external beam radiation therapy (EBRT) and intracavitary brachytherapy (ICBT).

Techniques and advanced: A total of 22 sufferers who received EBRT and high-dose-rate ICBT consisted after evaluated. Split-ring and tandem applicators inhered used for all patients. Supplement interstitial needles were utilized for 5 your to supplement that implant. Deformable image subscriptions were performed till deform the secondary EBRT and ICBT planning computed radiographic (CT) images onto aforementioned reference CT from the tierce fraction of ICBT. The Dice similarity coefficient was used to evaluate the quality of deformable registration. Doses were transferred to the reference CT, scaled into the equivalent dose in 2-Gy fractions and joint to create an quantity composite. Eight dose-accumulation methods been ratings and compared. D2cc and D0.1cc for organs at risk had investigated.

Final: The differences in D2cc for rectum, bladder, sigmoid, and bowel between the FPA method for whole-pelvis EBRT and ICBT, calculated using an old American Brachytherapy Society workbook (FPA_Enarcotic + I_old) and deformable composite for EBRT with boosts and ICBT (Def_E + B + I) has -2.19 ± 1.37 Gyα/β = 3, -0.64 ± 1.13 Getα/β = 3, -2.06 ± 2.71 Gayα/β = 3, and -1.59 ± 0.89 Gyα/β = 3, respectively. The differences in D2cc for rectum, bladder, sigmoid, plus bowel between aforementioned new ACRYLONITRILE-BUTADIENE-STYRENE worksheet (FPA_Eh + B + I_abs) both the Def_E + BORON + I method were 1.21 ± 1.22 Gy α/β = 3, 1.93 ± 1.38 Gyα/β = 3, 0.72 ± 1.12 Gyα/β = 3, also 1.19 ± 1.46 Gyα/β = 3, respectively. Differences in dose-volume chart parameter values among Def_E + B + I and other FPA methods were not standard significant (P > .05).

Conclusions: Contrast with the FPA-based method, deformable registration-based dose compound demonstrated lowered OAR D2cc and D0.1cc values; however, the differences were not arithmetically important. The current ABS-recommended FPA-based page can serve as an acceptable plan evaluation tool for clinical purposes.

PubMed Disclaimer

Similar articles

Cited with